Healthequity (HQY) Enterprise Value (2013 - 2026)

Healthequity's Enterprise Value history runs 14 years deep, the most recent figure standing at -$265.4 million for Q2 2026.

• On a quarterly basis, Enterprise Value rose 7.82% year-over-year to -$265.4 million in Q2 2026; TTM through Apr 2026 was -$265.4 million, a 7.82% increase from a year earlier, with the FY2026 full-year figure at -$318.9 million, down 7.76% from the prior year.
• Enterprise Value grew to -$265.4 million in Q2 2026 per HQY's latest filing, from -$318.9 million in the prior quarter.
• Across five years, Enterprise Value topped out at -$161.2 million in Q2 2022 and bottomed at -$404.0 million in Q1 2024.
• The 5-year median for Enterprise Value is -$289.1 million (2023), against an average of -$275.8 million.
• Across the five-year window, Enterprise Value surged 78.11% in 2022 and plunged 64.14% in 2023, its largest moves.
• Year by year, Enterprise Value stood at -$210.2 million in 2022, then slumped by 58.93% to -$334.1 million in 2023, then gained by 3.56% to -$322.2 million in 2024, then gained by 4.01% to -$309.3 million in 2025, then grew by 14.19% to -$265.4 million in 2026.
• Per Business Quant, the three latest HQY Enterprise Value figures stand at -$265.4 million (Q2 2026), -$318.9 million (Q1 2026), and -$309.3 million (Q4 2025).